abstract routine acceptance of use of hormone replacement therapy (hrt) was shattered in 2002 when results of the largest hrt randomised clinical trial, the women's health initiative, indicated that long term use of oestrogen plus progestin hrt not only was associated with increased risk of cancer but, contrary to expectations, did not decrease, and may have increased, risk of cardiovascular disease.